Oppenheimer Asset Management Inc. Has $364,000 Stake in Chemed Co. (NYSE:CHE)

Oppenheimer Asset Management Inc. trimmed its holdings in Chemed Co. (NYSE:CHEFree Report) by 3.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 687 shares of the company’s stock after selling 27 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Chemed were worth $364,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC grew its stake in shares of Chemed by 6.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 1,175 shares of the company’s stock worth $706,000 after buying an additional 75 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after purchasing an additional 324 shares during the period. Janney Montgomery Scott LLC lifted its holdings in shares of Chemed by 12.7% during the third quarter. Janney Montgomery Scott LLC now owns 12,660 shares of the company’s stock worth $7,608,000 after purchasing an additional 1,425 shares during the period. Van ECK Associates Corp lifted its holdings in shares of Chemed by 35.5% during the third quarter. Van ECK Associates Corp now owns 11,610 shares of the company’s stock worth $6,886,000 after purchasing an additional 3,043 shares during the period. Finally, QRG Capital Management Inc. lifted its holdings in shares of Chemed by 5.1% during the third quarter. QRG Capital Management Inc. now owns 1,368 shares of the company’s stock worth $822,000 after purchasing an additional 66 shares during the period. 95.85% of the stock is owned by institutional investors.

Insider Activity at Chemed

In other news, VP Brian C. Judkins bought 145 shares of the company’s stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the acquisition, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 3.32% of the stock is owned by company insiders.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday.

Check Out Our Latest Research Report on Chemed

Chemed Stock Down 0.1 %

CHE stock opened at $594.36 on Friday. The firm has a market cap of $8.95 billion, a price-to-earnings ratio of 30.03, a PEG ratio of 2.15 and a beta of 0.48. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The company’s fifty day simple moving average is $550.98 and its 200 day simple moving average is $563.76.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.34%. Chemed’s payout ratio is 10.05%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.